Saft, C. (2022). Huntington’s disease: disappointments and new beginnings. Lancet Neurology, 21(7), 582–584. https://doi.org/10.1016/s1474-4422(22)00189-2

Pinto, R. J., Arning, L., Giordano, J., Razghandi, P., Andrew, M. A., Gillis, T., Correia, K., Mysore, J. S., Urtubey, D. M. G., Parwez, C. R., Von Hein, S. M., Clark, H. L., Nguyen, H. P., Förster, E., Beller, A., Jayadaev, S., Keene, C. D., Bird, T. D., Lucente, D., Saft, C., . . . Wheeler, V. C. (2020). Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1. Human Molecular Genetics, 29(15), 2551–2567. https://doi.org/10.1093/hmg/ddaa139

Tabrizi, S. J., Leavitt, B. R., Landwehrmeyer, G. B., Wild, E. J., Saft, C., Barker, R. A., Blair, N. F., Craufurd, D., Priller, J., Rickards, H., Rosser, A., Kordasiewicz, H. B., Czech, C., Swayze, E. E., Norris, D. A., Baumann, T., Gerlach, I., Schobel, S. A., Paz, E., . . . Lane, R. M. (2019). Targeting Huntingtin Expression in Patients with Huntington's Disease. The New England Journal of Medicine, 380(24), 2307–2316. https://doi.org/10.1056/nejmoa1900907

Van Well, E. M., Bader, V., Patra, M., Sánchez-Vicente, A., Meschede, J., Furthmann, N., Schnack, C., Blusch, A., Longworth, J., Petrasch-Parwez, E., Haass, C., Arzberger, T., Trümbach, D., Angersbach, L., Showkat, C., Sehr, D. A., Berlemann, L. A., Goldmann, P. L., Clement, A. M., Saft, C., . . . Winklhofer, K. F. (2019). A protein quality control pathway regulated by linear ubiquitination. The EMBO Journal, 38(9). https://doi.org/10.15252/embj.2018100730

Saft, C. (2017). Identifying modifiers of Huntington’s disease progression. Lancet Neurology. https://doi.org/10.1016/s1474-4422(17)30179-5